NVCR Utang jangka cendhak marang ekuitas NovoCure

Logo grafis novocure.com (NVCR)

The market trend for NovoCure Limited (NVCR) observed on this price chart is based on the success of a non-toxic method for combating tumors via electric field influence, as confirmed by the 0.09 indicator. NovoCure Limited (NVCR) relies on exclusive patents in the field of physical suppression of cell division without the use of chemicals. The business is currently implementing AI control and automated assembly for its portable medical devices.

NVCR - Rasio utang jangka cendhak marang ekuitas NovoCure Ltd ing rentang 04.07.2022 - 01.11.2026

Rincian analitis perusahaan novocure.com (NVCR)

- kuotasi lan prakiraan analis:
Rega saham NovoCure Corp|NVCR - Target median analis
- data kapitalisasi pasar:
Nilai pasar NovoCure Ltd|NVCR - Rega Tumbas Perusahaan
- data ekuitas miturut neraca:
Nilai Buku saben Saham NovoCure|NVCR - Aset Bersih Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku novocure.com|NVCR - Aset Perusahaan
- rincian utang lan likuiditas:
Utang marang Ekuitas NovoCure Limited|NVCR - Utang jangka dawa marang ekuitas|Utang jangka cendhak marang ekuitas NovoCure|NVCR - Utang perusahaan|Utang-utang marang kapitalisasi buku NovoCure Ltd|NVCR - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan NovoCure|Rasio cepet novocure.com
- statistik bathi lan rasio pasar:
NVCR - Penghasilan resik perusahaan
Analisis umum perusahaan:NovoCure Corp
Produk mawa merek NovoCure

To assess the stability of NovoCure Limited (NVCR), it is essential to understand the extent to which operating cash flow from Tumor Treating Fields therapy covers current liabilities. By analyzing the ratio of short-term debt to equity, an investor can determine the proportion of debts due within one year relative to capital; a breach of the historical highs for this indicator signals rising hidden risks and a potential degradation of asset value.

Analisis perusahaan pesaing

Utang jangka cendhak marang modal DRTS|Koefisien utang jangka cendhak marang modal Fortress Biotech Corp|Utang jangka cendhak marang ekuitas Acrivon Therapeutics ACRV|Koefisien utang jangka cendhak marang modal Allarity Therapeutics Inc. (ALLR)